RETINA-AI Health, Inc. has developed artificial intelligence technology to enable the diabetic retinal exam to be done in the primary care setting. The company's HUMMINGBIRD DR 100™ is a cloud-based AI detector of diabetic retinopathy which interprets the retinal image and returns a PDF report within a few seconds.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/07/20 | $5,200,000 | Series A |
Bill Smith | undisclosed |
